Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus
Shanshan Hu, Xun Deng, Yanjiao Ma, Zhilei Li, Yuhang Wang, Yong Wang, Yong Wang, Yong Wang
Topics & Concepts
SaxagliptinDapagliflozinMedicineMetforminHealth economicsMathematicsInternal medicineType 2 Diabetes MellitusDiabetes mellitusSitagliptinEndocrinologyNursingPublic healthInsulinDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research